Skip to content

Clinical trials

Phase 3 Hemolysis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Phase: Phase 3 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20111
20151
20161
20171
20201
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.4
AO GENERIUM1
Assistance Publique - Hôpitaux de Paris1
Forma Therapeutics, Inc.1
GlaxoSmithKline1
Hospital de Clinicas de Porto Alegre1
Menzies School of Health Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis10
Hemoglobinuria, Paroxysmal5
Anemia3
Anemia, Hemolytic2
Anemia, Sickle Cell2
Hematologic Diseases2
Bone Marrow Diseases1
Genetic Diseases, Inborn1
Hemoglobinopathies1
Hemoglobinuria1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.